Komori
Human Metabolome Technologies (6090) · RiskFirst stated

Intensifying competition driven by the use of AI and declining demand for outsourced analysis

First written in FY2026. . Latest entry: FY2026.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Cloud Demand Volatility and Competitive Risks from AI Substitute ServicesA theme 8 companies write about · 8 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2026: 3 of 6 companies on the "Worse" side.

2 other companies' latest entry also says "First stated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2026First statedAnnual report

    「Although we believe that the digital biology era will also bring many opportunities to improve efficiency for our Company, the expansion of AI-based simulations may intensify competition in the research and development field and reduce demand for contract analysis.」

    The expansion of AI-based simulations was identified as a new risk that could intensify competition in the research and development field and reduce demand for contract analysis.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Human Metabolome Technologies yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Intensifying competition driven by the use of AI and declining demand for outsourced analysis | Human Metabolome Technologies,Inc. (6090) | Komori